- Home
- HCA vs PSX Comparison
HCA vs PSX Comparison
Compare HCA & PSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCA | PSX |
|---|---|---|
| Founded | 1968 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.7B | 97.4B |
| IPO Year | 2009 | 2011 |
Fundamental Metrics
Financial Performance| Metric | HCA | PSX |
|---|---|---|
| Price | $459.17 | $293.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 20 |
| Target Price | ★ $460.59 | $276.84 |
| AVG Volume (30 Days) | 1.2M | ★ 2.8M |
| Earning Date | 10-27-2026 | 10-28-2026 |
| Dividend Yield | 0.67% | ★ 1.76% |
| EPS Growth | 28.77 | ★ 116.23 |
| EPS | 7.15 | ★ 10.05 |
| Revenue | $75,600,000,000.00 | ★ $132,376,000,000.00 |
| Revenue This Year | $3.85 | $29.89 |
| Revenue Next Year | $3.91 | N/A |
| P/E Ratio | $65.54 | ★ $28.77 |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $353.99 | $126.92 |
| 52 Week High | $556.52 | $297.42 |
Technical Indicators
Market Signals| Indicator | HCA | PSX |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 70.69 |
| Support Level | $420.98 | $166.52 |
| Resistance Level | $487.09 | N/A |
| Average True Range (ATR) | 10.29 | 7.42 |
| MACD | 2.64 | 2.05 |
| Stochastic Oscillator | 65.25 | 92.59 |
Price Performance
Historical ComparisonAbout HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
About PSX Phillips 66
Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.